Microgenesis
A new fertility test and treatment for women everywhere
Microgenesis is a company in diagnostics based in Argentina, founded in 2019.
Profile
Microgenesis offers a new fertility test and treatment that restores the fertility potential of women everywhere with a three-month, drug-free treatment. Microgenesis’ diagnostic detects subclinical inflammation that harms ovarian function and implantation. Microgenesis has proven their validity on the toughest cases: women who have already failed multiple IVF implantations.
The company sits in the diagnostics segment, where it competes on its core product or service.
Its base of operations is Argentina.
It is recorded at the SOSV portfolio company stage.
Recorded headcount: 2-10 employees.
It has disclosed roughly $6K in funding.
| Sector | Diagnostics |
|---|---|
| Country | Argentina |
| Founded | 2019 |
| Employees | 2-10 |
| Stage | SOSV portfolio company |
| Total funding | $600,000 |
Website: microgenesis.net
Create a free account